NCT02371330View on ClinicalTrials.gov

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Thrombocytopenia
Trial Locations (2)

28203

Department of Pediatrics, Levine Children's Hospital, Carolinas Healthcare System, Charlotte

171 76

Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

lead

Karolinska Institutet

OTHER

NCT02371330 - The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study | Biotech Hunter | Biotech Hunter